• About us
• Contact

Advertisement

Product › Details

Liquid Array™ TB panel

	Next higher product group	real-time PCR test (clinical diagnostics)
	Status	2019-01-07 development existent
	Organisation	Hain Lifescience GmbH
	Group	Bruker (Group)

Bruker Corporation. (2/1/19). "Press Release: Bruker Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference". Billerica, MA.

Bruker Corporation (NASDAQ: BRKR) announced today it will participate in the 37th annual J.P. Morgan Healthcare Conference in San Francisco. Frank Laukien, Chairman, President & CEO and Gerald Herman, CFO will present on behalf of the company on Monday, January 7th, 2019 at 9:00 AM Pacific Time.

A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at https://ir.bruker.com . A replay of the presentation will be posted in the "Events & Presentations" section of the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.

[ Presentation on 7 Jan accessed on 26th January 2019 via https://s22.q4cdn.com/617463959/files/doc_presentations/2019/01/JPM19HCC-BRKR-FINAL-04Jan19.pdf ]


About Bruker Corporation (NASDAQ: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com.


Contact :

Miroslava Minkova
Director, Investor Relations & Corporate Development
Bruker Corporation
T: +1 (978) 663 – 3660, ext. 1479
E: Miroslava.Minkova@Bruker.com

Record changed: 2023-07-10

Advertisement

More documents for real-time PCR test (clinical diagnostics)

• [1] BioEcho Life Sciences GmbH. (5/10/21). "Press Release: BioEcho Receives CE-IVD Mark Approval for SARS-CoV-2 RNA Extraction Kit". Cologne....
• [2] Novigenix S.A.. (9/19/19). "Press Release: Novigenix and BioLizard Sign Collaboration Agreement for Development of NGS Based Diagnostic Algorithm". Lausanne....
• [3] Altona Diagnostics GmbH. (2/7/19). "Press Release: Altona Diagnostics Receives CE-IVD Mark for HCV RT-PCR Test". Hamburg....
• [4] Bruker Corporation. (10/16/18). "Press Release: Bruker Completes Acquisition of Majority Interest in Infectious Disease Molecular Diagnostics Company Hain Lifescience GmbH". Billerica, MA....
• [5] GNA Biosolutions GmbH. (3/24/18). "Press Release: Multidisciplinary Consortium Announces Launch of PITBUL, an International Collaboration for the Development of Ultrafast Tuberculosis Diagnostics". Martinsried....
• [6] Qiagen N.V.. (1/23/18). "Press Release: Qiagen Receives FDA Clearance for First-ever JAK2 Test for Use in Diagnosis of Additional Myeloproliferative Neoplasms". Hilden & Germantown, MD....
• [7] BioNTech Diagnostics GmbH. (1/15/18). "Press Release: BioNTech Announces Results from Two More Studies Demonstrating the Benefits of Breast Cancer Subtyping Using Mammatyper". Mainz....
• [8] Roche. (1/4/18). "Press Release: Roche Launches the cobas Plasma Separation Card to Increase Access to HIV testing for Patients Living in Remote Areas". Basel....
• [9] Fast Track Diagnostics S.à.r.l.. (12/5/17). "Press Release: Fast Track Diagnostics and UgenTec Announce New Interpretation Software for All FTD Real-time PCR Multiplex Kits". Luxembourg & Hasselt....
• [10] Qiagen N.V.. (3/29/17). "Press Release: Qiagen Launches First FDA-cleared JAK2 Test for Certain Type of Leukemia". Germantown, MD & Hilden....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.